Invitrogen Corporation

(NASDAQ:IVGN)

22.82

-1.29 (-5.35%)

2:18ET Delayed

Open
23.80
High
23.80
Low
22.53
Vol.
2.63M
Mkt Cap
2.11B
52Wk High
49.58
52Wk Low
19.56
Avg. Vol.
3.86M
P/E (Trailing)
12.46
Beta
-0.15
Short %
18.70%
Div. Yield
—

Company Profile

Invitrogen Corporation

5791 Van Allen Way

Carlsbad, CA 92008

United States - Map

Phone: (760) 603-7200

Fax: (760) 602-6500

Website: www.invitrogen.com

State of incorporation: Delaware

CEO: Gregory T. Lucier

Employees: 4,300

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biological products.

A developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological product

Recent news for IVGN

Recent opinions on IVGN

No recent Opinions for IVGN

Top members owning IVGN

  • Top 27%

    ambaz1

    ambaz1

    -14.29%3m:

    -14.29%YTD:

  • Top 37%

    jillnolan

    jillnolan

    -23.22%3m:

    -23.22%YTD:

  • Top 76%

    avivsher

    avivsher

    -44.69%3m:

    -52.77%YTD:

Members owning IVGN also own

NNBR (20.00%), CCK (20.00%), MMR (20.00%), WLP (20.00%), NWSB (20.00%)

Member sentiment: Neutral